Isogenica will be attending Bio-Europe and will be represented by newly appointed CEO Emma Sceats and commercial director Adam collier. This will be an exciting opportunity for us to talk to potential partners about Isogenicas state-of-the-art synthetic antibody libraries and their in accelerating therapeutic antibody discovery.

 

Please contact sales@isogenica to highlight any interest to meet in advace of our attendance. 

 

 

https://ebdgroup.knect365.com/bioeurope/